Deutsche Märkte geschlossen

BICO Group AB (publ) (CLLKF)

Other OTC - Other OTC Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
4,0000+0,1960 (+5,15%)
Börsenschluss: 09:29AM EDT

BICO Group AB (publ)

Långfilsgatan 9
Gothenburg 412 77
Sweden
46 7 35 46 57 77
https://www.bico.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter880

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Ms. Maria ForssPresident & CEO7,43MN/A1972
Mr. Erik GatenholmCo-Founder & Director6,57MN/A1989
Mr. Jacob ThordenbergGroup Chief Financial OfficerN/AN/A1985
Mr. Marius BalgerChief Operating OfficerN/AN/AN/A
Ms. Asa HillstenSenior VP & Head of Investor RelationsN/AN/A1975
Lotta BusSVP, General Counsel, Secretary & HRN/AN/A1970
Mr. Artur AiraHead of Corporate Development and M&A150kN/A1967
Ms. Catharina NordlundGlobal Head of Human ResourcesN/AN/AN/A
Ms. Itedale Namro RedwanChief Scientific Officer - BioprintingN/AN/AN/A
Niclas EmanuelssonHead of Global OperationsN/AN/A1971
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.

Corporate Governance

BICO Group AB (publ)s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 5. Die grundlegenden Scores sind Audit: 4, Vorstand: 1, Shareholderrechte: 7, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.